91 related articles for article (PubMed ID: 17114818)
1. Upregulation of metallothionein-I mRNA expression in a rodent model for amyotrophic lateral sclerosis.
Ono S; Endo Y; Tokuda E; Ishige K; Tabata K; Asami S; Ito Y; Suzuki T
Biol Trace Elem Res; 2006 Oct; 113(1):93-104. PubMed ID: 17114818
[TBL] [Abstract][Full Text] [Related]
2. Metallothionein proteins expression, copper and zinc concentrations, and lipid peroxidation level in a rodent model for amyotrophic lateral sclerosis.
Tokuda E; Ono S; Ishige K; Naganuma A; Ito Y; Suzuki T
Toxicology; 2007 Jan; 229(1-2):33-41. PubMed ID: 17097207
[TBL] [Abstract][Full Text] [Related]
3. Expression of different metallothionein messenger ribonucleic acids in motor cortex, spinal cord and liver from patients with amyotrophic lateral sclerosis.
Blaauwgeers HG; Anwar Chand M; van den Berg FM; Vianney de Jong JM; Troost D
J Neurol Sci; 1996 Oct; 142(1-2):39-44. PubMed ID: 8902718
[TBL] [Abstract][Full Text] [Related]
4. Metallothionein expression is altered in a transgenic murine model of familial amyotrophic lateral sclerosis.
Gong YH; Elliott JL
Exp Neurol; 2000 Mar; 162(1):27-36. PubMed ID: 10716886
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of metallothionein-I, a copper-regulating protein, attenuates intracellular copper dyshomeostasis and extends lifespan in a mouse model of amyotrophic lateral sclerosis caused by mutant superoxide dismutase-1.
Tokuda E; Okawa E; Watanabe S; Ono S
Hum Mol Genet; 2014 Mar; 23(5):1271-85. PubMed ID: 24163136
[TBL] [Abstract][Full Text] [Related]
6. Effect of neuroprotective drugs on gene expression in G93A/SOD1 mice.
Ignacio S; Moore DH; Smith AP; Lee NM
Ann N Y Acad Sci; 2005 Aug; 1053():121-36. PubMed ID: 16179515
[TBL] [Abstract][Full Text] [Related]
7. Disease progression in a transgenic model of familial amyotrophic lateral sclerosis is dependent on both neuronal and non-neuronal zinc binding proteins.
Puttaparthi K; Gitomer WL; Krishnan U; Son M; Rajendran B; Elliott JL
J Neurosci; 2002 Oct; 22(20):8790-6. PubMed ID: 12388585
[TBL] [Abstract][Full Text] [Related]
8. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
[TBL] [Abstract][Full Text] [Related]
9. L-Citrulline Level and Transporter Activity Are Altered in Experimental Models of Amyotrophic Lateral Sclerosis.
Gyawali A; Gautam S; Hyeon SJ; Ryu H; Kang YS
Mol Neurobiol; 2021 Feb; 58(2):647-657. PubMed ID: 33000451
[TBL] [Abstract][Full Text] [Related]
10. Kif1Bbeta isoform is enriched in motor neurons but does not change in a mouse model of amyotrophic lateral sclerosis.
Conforti L; Dell'Agnello C; Calvaresi N; Tortarolo M; Giorgini A; Coleman MP; Bendotti C
J Neurosci Res; 2003 Mar; 71(5):732-9. PubMed ID: 12584731
[TBL] [Abstract][Full Text] [Related]
11. Exercise induces metallothioneins in mouse spinal cord.
Hashimoto K; Hayashi Y; Inuzuka T; Hozumi I
Neuroscience; 2009 Sep; 163(1):244-51. PubMed ID: 19490933
[TBL] [Abstract][Full Text] [Related]
12. Metallothionein in amyotrophic lateral sclerosis.
Sillevis Smitt PA; Mulder TP; Verspaget HW; Blaauwgeers HG; Troost D; de Jong JM
Biol Signals; 1994; 3(4):193-7. PubMed ID: 7834014
[TBL] [Abstract][Full Text] [Related]
13. Metallothionein-III prevents neuronal death and prolongs life span in amyotrophic lateral sclerosis model mice.
Hashimoto K; Hayashi Y; Watabe K; Inuzuka T; Hozumi I
Neuroscience; 2011 Aug; 189():293-8. PubMed ID: 21640795
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Motor Neuron Prostaglandin E2 EP3 Receptor Isoform in a Mouse Model of Amyotrophic Lateral Sclerosis.
Kosuge Y; Miyagishi H; Shinomiya T; Nishiyama K; Suzuki S; Osada N; Ishige K; Okubo M; Kawaguchi M; Ito Y
Biol Pharm Bull; 2015; 38(12):1964-8. PubMed ID: 26632188
[TBL] [Abstract][Full Text] [Related]
15. Dysequilibrium between caspases and their inhibitors in a mouse model for amyotrophic lateral sclerosis.
Tokuda E; Ono S; Ishige K; Watanabe S; Okawa E; Ito Y; Suzuki T
Brain Res; 2007 May; 1148():234-42. PubMed ID: 17397813
[TBL] [Abstract][Full Text] [Related]
16. Temporal patterns of cytokine and apoptosis-related gene expression in spinal cords of the G93A-SOD1 mouse model of amyotrophic lateral sclerosis.
Hensley K; Floyd RA; Gordon B; Mou S; Pye QN; Stewart C; West M; Williamson K
J Neurochem; 2002 Jul; 82(2):365-74. PubMed ID: 12124437
[TBL] [Abstract][Full Text] [Related]
17. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
[TBL] [Abstract][Full Text] [Related]
18. The Overexpression of TDP-43 Protein in the Neuron and Oligodendrocyte Cells Causes the Progressive Motor Neuron Degeneration in the SOD1 G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.
Lu Y; Tang C; Zhu L; Li J; Liang H; Zhang J; Xu R
Int J Biol Sci; 2016; 12(9):1140-9. PubMed ID: 27570488
[TBL] [Abstract][Full Text] [Related]
19. Cytokine upregulation in a murine model of familial amyotrophic lateral sclerosis.
Elliott JL
Brain Res Mol Brain Res; 2001 Nov; 95(1-2):172-8. PubMed ID: 11687290
[TBL] [Abstract][Full Text] [Related]
20. Reduction of metallothioneins promotes the disease expression of familial amyotrophic lateral sclerosis mice in a dose-dependent manner.
Nagano S; Satoh M; Sumi H; Fujimura H; Tohyama C; Yanagihara T; Sakoda S
Eur J Neurosci; 2001 Apr; 13(7):1363-70. PubMed ID: 11298796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
